CELLSEARCH BIOTECH LIMITED
Executive Summary
CellSearch Biotech Limited is an early-stage micro-entity within the specialized scientific research sector, currently exhibiting minimal financial activity consistent with a pre-operational start-up. While it is positioned to leverage sector trends favoring innovation and R&D, its competitive standing is nascent relative to established peers with broader resources and operational footprints. Strategic development and capital infusion will be critical for it to advance beyond its initial formation phase.
View Full Analysis Report →- Legal registered address
- Dickens House Guithavon Street Witham Essex England CM8 1BJ Copied!
Latest financial results as of 31 August 2025- Current assets
- £100
- Shareholders funds
- £100
View full financial accounts- Current assets
- £100
- Shareholders funds
- £100
- Company number
- 15075406 Copied!
Accounts
Latest annual accounts were to 31 August 2024
Next annual accounts are due by 31 December 2025
Company financial year end is on 31 March 2026
Confirmation statement
Latest confirmation statement statement dated 15 August 2025
Next statement due by 29 August 2026
Nature of business (SIC)
72190 - Other research and experimental development on natural sciences and engineering
Latest company documents
Date | Description |
---|---|
18/08/2518 August 2025 New | Confirmation statement made on 2025-08-15 with updates |
16/07/2516 July 2025 New | Previous accounting period shortened from 2025-08-31 to 2025-03-31 |
16/07/2516 July 2025 New | Appointment of Mr Yaniv Ariel Tivon as a director on 2025-07-01 |
16/07/2516 July 2025 New | Termination of appointment of Philip Lawrence as a director on 2025-07-01 |
16/07/2516 July 2025 New | Notification of Yaniv Ariel Tivon as a person with significant control on 2025-07-01 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company